Talk:Neuroendocrine neoplasms: Difference between revisions
Jump to navigation
Jump to search
Created page with "==NET vs NEC== *NET G3: no p16 abnormality, no p53 *NEC: p16 block +ve, p53 mut, KRAS mut" |
No edit summary |
||
| Line 2: | Line 2: | ||
*NET G3: no p16 abnormality, no p53 | *NET G3: no p16 abnormality, no p53 | ||
*NEC: p16 block +ve, p53 mut, KRAS mut | *NEC: p16 block +ve, p53 mut, KRAS mut | ||
==NE component - present or absent== | |||
See: [[Talk:Prostate cancer with neuroendocrine differentiation]] | |||
Latest revision as of 22:16, 4 March 2024
NET vs NEC
- NET G3: no p16 abnormality, no p53
- NEC: p16 block +ve, p53 mut, KRAS mut
NE component - present or absent
See: Talk:Prostate cancer with neuroendocrine differentiation